5 results about "Induced Abortions" patented technology

This invention discloses the application of ethinylestradiol and drospirenone in the preparation of drugs for treating post-traumatic stress disorder (PTSD). Ethinylestradiol, as an estrogen receptor agonist, regulates the hypothalamic-pituitary-gonadal axis and is used to treat female hypogonadism, menopausal syndrome, and advanced breast cancer, often in combination with progestins as oral contraceptives. The use of drospirenone and ethinylestradiol tablets (II) after induced abortion can shorten vaginal bleeding time, promote endometrial repair, and reduce the incidence of postoperative complications and repeat miscarriages. This invention has found that ethinylestradiol and drospirenone can reverse the abnormal decrease in hormones and neurosteroids caused by PTSD after spontaneous abortion, particularly the abnormal decrease in serotonin and tetrahydroprogesterone.

The invention provides a leakproof hysteroscope, and relates to the field of medical instruments, the leakproof hysteroscope comprises a main pipe, one end of the main pipe is fixedly connected with an extension pipe, the surface of the extension pipe is sleeved with an air bag part, the top of the outer arc surface of one end of the air bag part is provided with a liquid inlet pipe, the middle of the main pipe is movably clamped with a support, and one end of the liquid inlet pipe is movably clamped on the support; connecting pieces are fixedly connected to the bottoms of the outer surfaces of the main pipes. Through the arrangement of the support, the air bag part, the liquid inlet pipe, the water stop ball, the connecting rod, the temporary storage part and the flowing groove, liquid injection operation on the device is achieved, the air bag part is effectively expanded, the inner wall of the cervix uteri is gradually extruded and attached, then the gap between the cervix uteri and the device is reduced, medium leakage is effectively avoided, and the problem that in the prior art, in the using process, medium leakage is caused is solved. Cervical relaxation of a patient is very easy to occur due to fetus, normal delivery, uterine curettage or multiple induced abortion times, frequent perineal examination, delivery injury and the like, and the problem of medium leakage is very easy to occur due to the fact that the number of the cervical relaxation is combined with cervical hypertrophy.

The utility model discloses a device for filtering pregnancy tissue in induced abortion surgery, which comprises a bottle body, a filter screen, a cover body and a clamping piece, the filter screen is arranged at the central position in the bottle body, the cover body is arranged at the top end of the bottle body, a suction tube is arranged at one end of the top of the cover body, and the bottom end of the suction tube extends into the filter screen. A negative pressure pipe is arranged at the other end of the top of the cover body, the bottom end of the negative pressure pipe extends into the bottle body on one side of the filter screen, clamping pieces are arranged on the tops of the two sides of the bottle body through rotating seats, clamping blocks are arranged on the two sides of the cover body, and magnet blocks are embedded into the clamping blocks. By installing the bottle body, the filter screen, the negative pressure pipe, the suction pipe, the cover body, the rotating seat, the clamping pieces, the clamping blocks and the magnet blocks, the cover body can be opened by pulling the clamping pieces on the two sides of the bottle body outwards to be separated from the clamping blocks on the cover body, pregnancy tissue sucked out from the inside can be conveniently examined, and operation is convenient.

The invention provides application of blood nourishing oral liquid combined with drospirenone ethinylestradiol in clinical symptoms and endometrial receptivity after an induced abortion operation, and belongs to the technical field of biological medicine. According to the application of the blood nourishing oral liquid and the drospirenone ethinylestradiol in preparation of the medicine for improving the clinical symptoms after the induced abortion operation, the result of the embodiment shows that compared with a drospirenone ethinylestradiol single administration group, the combined administration group has the advantages that the vaginal bleeding duration is shorter, the vaginal bleeding amount is smaller, the abdominal pain degree is lower, and the clinical symptoms after the induced abortion operation can be improved. The dominant follicle size, the endometrial thickness, the endometrial volume, the type A endometrial rate, the type III endometrial and the ratio of the endometrial-muscular layer binding band are all higher than those of a control group, and the aneurysm hemodynamic indexes are all lower than those of a single administration group. Therefore, the blood-nourishing oral liquid combined with drospirenone ethinylestradiol can effectively improve postoperative clinical symptoms of patients, promote follicle development and improve endometrial receptivity.

The invention discloses a drug abortion success rate prediction system and method based on a random forest, particularly relates to the technical field of medical data analysis, and aims to solve the problem that clinical doctors depend on experience to judge the success rate of drug abortion and lack scientific and quantitative prediction tools. The method comprises the following steps: firstly, selecting a target population which requires drug abortion and has no contraindication, and collecting clinical data of the target population; making a binarization coding rule, coding the collected clinical data of the target population item by item, and constructing a feature vector of the target population; based on the feature vector of the target population, predicting whether the drug abortion of the patient succeeds or not through a random forest model; then collecting the drug abortion outcome of the target population; and finally, merging the drug abortion outcome and the clinical data-data model of the patient to obtain a predicted value of the drug abortion outcome of the patient. According to the invention, the evaluation system for the adaptive population of the drug-induced abortion is established, the adaptive population of the drug-induced abortion is defined, and the failure rate of the drug-induced abortion is reduced.